Mitchell P. Kopin 13D and 13G filings for Moleculin Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-06 5:26 pm Purchase | 2026-07-31 | 13G | MOLECULIN BIOTECH INC PAR MBRX | Mitchell P. Kopin | 973,927 4.990% | 973,593 (+291494.91%) | Filing |